L
Lexicon Pharmaceuticals (LXRX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Lexicon Pharmaceuticals (LXRX)
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its pipeline includes Sotagliflozin, LX9211, and ... Read more
- USD0.66
- USD0.68
- USD0.62
- USD2.45
- -1.30%
- 31M
- 3.02M
- 4.14M
- 254M
- 0.28
- -59.80%
Stock News
1 hour ago
Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure
MarketWatch
1 hour ago
Meta makes a big move into defense. Here's how it could start to matter for investors
CNBC
2 hours ago
Ulta Beauty Soars 11.2% on Earnings Beat and Upgraded Outlook
Yahoo
2 hours ago
Elon Musk deflects question about report of drug use, family drama as Trump looks on
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
